Does red-man reaction stimulate macrophage activation syndrome in children with systemic juvenile idiopathic arthritis?

Journal of Rheumatology

Volumn 34, Issue 12, 2007, Pages 2491-2494

  Olgar, Seref ^a   Ertugrul, Turkan ^a   Devecioglu, Omer ^a   Nisli, Kemal ^a   Omeroglu, Rukiye Eker ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Macrophage activation syndrome; Red man syndrome; Systemic juvenile idiopathic arthritis; Vancomycin

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; ANTIFUNGAL AGENT; BLOOD CLOTTING FACTOR 7; CEFTRIAXONE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; FIBRINOGEN; FLUCONAZOLE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; METICILLIN; NAPROXEN; NETILMICIN; PENICILLIN V; STEROID; VANCOMYCIN;

ADOLESCENT; ARTICLE; BLEEDING; CASE REPORT; CHILD; CYTOPENIA; ECHOCARDIOGRAPHY; ENDOCARDITIS; FEMALE; FEVER; FLUSHING; HUMAN; HYPOTENSION; INTESTINAL BLEEDING; JUVENILE RHEUMATOID ARTHRITIS; LIVER FAILURE; MACROPHAGE ACTIVATION; MACROPHAGE ACTIVATION SYNDROME; MALE; NAUSEA; PANCYTOPENIA; PATIENT CARE; PRIORITY JOURNAL; RASH; RESPIRATORY DISTRESS; SHOULDER PAIN; SIDE EFFECT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VOMITING;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; FEMALE; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; SYNDROME; TREATMENT OUTCOME; VANCOMYCIN;

EID: 36849020599     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. De Benedetti F, Martini A. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated diseases? J Rheumatol 1998;25:203-7.
2. Weiss JE, Ilowite NT. Juvenile idiopathic arthritis. Pediatr Clin North Am 2005;52:413-42.
3. Grom AA. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 2004;50:689-98.
4. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-52.
5. Maeno N, Takei S, Imanaka H, et al. Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome. Arthritis Rheum 2004;50:1935-8.
6. Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology Oxford 2003;42:375-9.
7. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292-6.
8. Villanueva J, Lee S, Giannini EH, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005;7:R30-7.
9. Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol 2003;15:587-90.
10. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
11. Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005;146:598-604.
12. Esumi N, Ikushima S, Hibi S, Todo S, Imashuku S. High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 1988;61:2071-6.
13. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine Baltimore 1988;67:369-88.
14. McEvoy GK. Vancomycin. In: American Hospital Formulary Service Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists; 2004:152-3.
15. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14.
16. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
17. Nicholson JF, Pesce MA. Reference ranges for laboratory tests and procedures. In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. Philadelphia, PA: Saunders; 2004:2396-427.